Pediatric Critical Care Medicine · 2019 · 40 citations · 19 references
MedicineNeurologyPediatricsEpilepsyEpileptologyPediatric NeurologyEpilepsy ImagingEpilepsy In ChildhoodEtiology Of EpilepsySeizure DisordersSeizure ManagementStatus EpilepticusCryptogenic Status EpilepticusNeurocognitive DeficitsNeurocognitive ProfileOutcome MeasuresPediatric Status EpilepticusRefractory Status EpilepticusStatus Epilepticus In ChildrenSuper-refractory Status Epilepticus
OBJECTIVES: To elucidate etiologies, treatment, functional and neurocognitive outcomes of children with new-onset refractory status epilepticus. DESIGN: A single-center retrospective study. SETTING: A tertiary care children's hospital. PATIENTS: All patients between 1 month and 21 years old admitted with new-onset refractory status epilepticus between January 2004 and July 2017. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Clinical presentation, laboratory data, imaging studies, and treatments were collected during hospitalization. Outcomes were assessed at hospital discharge and follow-up in the outpatient neurology clinic based on functional and neurocognitive outcomes as well as development of epilepsy. A total of 674 unique patients presented with status epilepticus of which 40 had new-onset refractory status epilepticus. Patients were classified into either refractory status epilepticus or super-refractory status epilepticus. The etiology of most children with new-onset refractory status epilepticus remained cryptogenic. The most common identified etiology was viral (20%). None of the patients had a contributory positive neuronal antibody test. Several treatments were tried including immunotherapy which was used in half of the patients. Five patients died (12.5%) during the acute phase of their disease, with four lost to follow-up. Twenty out of the remaining 31 patients (65%) developed epilepsy and 18 (58%) had persistent neurocognitive impairment. There was no statistical significant difference in various outcome measures and various etiologies, patients' characteristics, and treatments. CONCLUSIONS: In this single-center cohort, more than half of the children with new-onset refractory status epilepticus did not have an identifiable etiology. Unlike adult patients, the presence of positive neuronal antibody syndrome was rare. There was no difference in outcome between those with or without an identifiable etiology. As expected, patients with super-refractory status epilepticus had worse functional and neurocognitive outcomes. More standardized diagnostic and treatment algorithms are needed along with prospective multicenter studies.
19
Lauren Krupp, Marc Tardieu, Maria Pia Amato et al. · Multiple Sclerosis Journal · 2013 · 1.1K citations
Medicine, Neurology, Pediatrics +15
Acute disseminated encephalomyelitis
Sílvia Tenembaum, Néstor Chamoles, Natalio Fejerman · Neurology · 2002 · 711 citations
Medicine, Neurology, Pediatrics +13
New-onset refractory status epilepticus
Nicolas Gaspard, Brandon Foreman, Vincent Alvarez et al. · Neurology · 2015 · 481 citations · Full text
Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome
Uri Kramer, Ching-Shiang Chi, Kuang-Lin Lin et al. · Epilepsia · 2011 · 318 citations · Full text